Outcomes for surgical procedures funded by the English health service but carried out in public versus independent hospitals: a database study.


Journal

BMJ quality & safety
ISSN: 2044-5423
Titre abrégé: BMJ Qual Saf
Pays: England
ID NLM: 101546984

Informations de publication

Date de publication:
07 2022
Historique:
received: 13 04 2021
accepted: 08 07 2021
pubmed: 9 9 2021
medline: 23 6 2022
entrez: 8 9 2021
Statut: ppublish

Résumé

The outcomes of elective surgery in public versus Independent Sector Healthcare Providers (ISHPs) are a matter of policy relevance and theoretical interest. Retrospective study of all National Health Service (NHS) hospitals and ISHPs in England that provided NHS-funded elective surgery. We used data from the England-wide Hospital Episode Statistics to study 18 common surgical procedures performed between 2006 and 2019. In-hospital outcomes included length of stay, emergency transfers to another hospital or death. Posthospital outcomes included readmission or death within 28 days. Outcomes were compared for each operation type by propensity score matching and survival analysis. The data set included 3 203 331 operations in 734 NHS hospitals and 468 259 operations in 274 ISHPs.In-hospital outcomes: Across all 18 included operation types, length of stay was significantly longer for patients treated in NHS hospitals compared with ISHPs. Effect sizes ranged from a hazard ratio (HR) of 2.15 (95% CI 1.72 to 2.68) for total hip replacement to 1.07 (95% CI 1.05 to 1.09) for wisdom tooth removal; a mean difference of 2.49 and 0.02 days, respectively.Postdischarge outcomes: Treatment at an ISHP was associated with a lower risk of emergency readmission compared with NHS treatment. HRs ranged from 0.36 (95% CI 0.28 to 0.46) for lumbar decompression to 0.75 (95% CI 0.67 to 0.85) for cholecystectomy; absolute risk differences of 1.5 and 1.3 percentage points. There was no difference in mortality. Elective surgery in an ISHP is associated with shorter lengths of stay and lower readmission rates than treatment in NHS hospitals across 18 operation types. The data were matched on observable covariates, but we cannot exclude selection bias due to unobserved confounders.

Sections du résumé

BACKGROUND
The outcomes of elective surgery in public versus Independent Sector Healthcare Providers (ISHPs) are a matter of policy relevance and theoretical interest.
METHODS
Retrospective study of all National Health Service (NHS) hospitals and ISHPs in England that provided NHS-funded elective surgery. We used data from the England-wide Hospital Episode Statistics to study 18 common surgical procedures performed between 2006 and 2019. In-hospital outcomes included length of stay, emergency transfers to another hospital or death. Posthospital outcomes included readmission or death within 28 days. Outcomes were compared for each operation type by propensity score matching and survival analysis.
RESULTS
The data set included 3 203 331 operations in 734 NHS hospitals and 468 259 operations in 274 ISHPs.In-hospital outcomes: Across all 18 included operation types, length of stay was significantly longer for patients treated in NHS hospitals compared with ISHPs. Effect sizes ranged from a hazard ratio (HR) of 2.15 (95% CI 1.72 to 2.68) for total hip replacement to 1.07 (95% CI 1.05 to 1.09) for wisdom tooth removal; a mean difference of 2.49 and 0.02 days, respectively.Postdischarge outcomes: Treatment at an ISHP was associated with a lower risk of emergency readmission compared with NHS treatment. HRs ranged from 0.36 (95% CI 0.28 to 0.46) for lumbar decompression to 0.75 (95% CI 0.67 to 0.85) for cholecystectomy; absolute risk differences of 1.5 and 1.3 percentage points. There was no difference in mortality.
CONCLUSION
Elective surgery in an ISHP is associated with shorter lengths of stay and lower readmission rates than treatment in NHS hospitals across 18 operation types. The data were matched on observable covariates, but we cannot exclude selection bias due to unobserved confounders.

Identifiants

pubmed: 34493605
pii: bmjqs-2021-013522
doi: 10.1136/bmjqs-2021-013522
pmc: PMC9234423
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

515-525

Subventions

Organisme : Department of Health
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMC Health Serv Res. 2008 Apr 09;8:78
pubmed: 18400096
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
BMJ. 2011 Oct 19;343:d6404
pubmed: 22012180
J R Soc Med. 2010 Aug 1;103(8):322-31
pubmed: 20610618
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Health Econ. 2013 Feb;22(2):234-42
pubmed: 22223593
Sociol Methodol. 2012 Aug;42(1):314-347
pubmed: 23482633
BMC Health Serv Res. 2018 Nov 16;18(1):863
pubmed: 30445942
J Public Health (Oxf). 2012 Mar;34(1):138-48
pubmed: 21795302
Int J Epidemiol. 2017 Aug 1;46(4):1093-1093i
pubmed: 28338941
BMJ. 2020 Feb 19;368:m362
pubmed: 32075796

Auteurs

Hannah Crothers (H)

Health Informatics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Adiba Liaqat (A)

Health Informatics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Katharine Reeves (K)

Health Informatics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Samuel I Watson (SI)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Suzy Gallier (S)

Health Informatics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Kamlesh Khunti (K)

Diabetes Research Centre, University of Leicester, Leicester, UK.

Paul Bird (P)

Institute for Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
West Midlands Academic Health Science Network, Birmingham, UK.

Richard Lilford (R)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK r.j.lilford@bham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH